What is the ICD-10 (International Classification of Diseases, 10th Revision) code for Sickle Cell Disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The ICD-10 code for sickle cell disease is D57, as indicated in the most recent study 1. This code is used to represent sickle cell disease in general, with several more specific subcodes depending on the exact type and manifestations of the disease.

  • The main code D57.1 represents sickle cell disease without crisis,
  • while D57.0 indicates sickle cell anemia with crisis. For more specific documentation,
  • D57.2 is used for double heterozygous sickling disorders,
  • D57.3 for sickle cell trait,
  • D57.4 for sickle cell thalassemia,
  • and D57.8 for other sickle cell disorders. When coding sickle cell disease, it's essential to document any acute complications or crises with additional codes, such as D57.00 for vaso-occlusive crisis or D57.01 for acute chest syndrome, as supported by recent research 2. Proper coding is crucial for accurate medical records, appropriate reimbursement, and tracking disease prevalence. Sickle cell disease is a genetic blood disorder characterized by abnormal hemoglobin that causes red blood cells to become rigid and sickle-shaped, leading to vascular occlusion, chronic hemolytic anemia, and organ damage, as described in 3 and 4. The importance of accurate coding is further emphasized by the need for standardized codes for complications and comorbidities associated with sickle cell disease, as highlighted in 2. Overall, the use of the ICD-10 code D57 and its subcodes is essential for effective management and tracking of sickle cell disease, as supported by the latest evidence 1, 2.

References

Research

[Sickle Cell Disease in Newborns in Germany: Analysis of the AOK Health Insurance Data].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 2019

Research

Sickle Cell Disease.

Annals of internal medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.